Pierre Drouin

Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer

Ate G.J. van der Zee, Maaike H.M. Oonk, Joanne A. de Hullu et al. · Journal of Clinical Oncology · 2008 · 789 citations · Full text

Phase III Trial Comparing Radical Radiotherapy With and Without Cisplatin Chemotherapy in Patients With Advanced Squamous Cell Cancer of the Cervix

R. Pearcey, Michael Brundage, Pierre Drouin et al. · Journal of Clinical Oncology · 2002 · 288 citations

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

Bruno Guerci, Pierre Drouin, Valerie Grange et al. · Diabetes & Metabolism · 2003 · 288 citations

Metabolic Syndrome, Diabetes Management, Health Policy +7

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study

Maaike H.M. Oonk, Bettien M. van Hemel, Harry Hollema et al. · The Lancet Oncology · 2010 · 259 citations

Surgical Oncology, Vulvar Diseases, Multicentre Observational Study +9

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

K. Swenerton, J Jeffrey, Gavin Stuart et al. · Journal of Clinical Oncology · 1992 · 214 citations